Overview

Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
Comparing Safety and Efficacy of Combigan® and Lumigan® with Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated with Xalatan®.
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost
Brimonidine Tartrate
Brimonidine Tartrate, Timolol Maleate Drug Combination
Maleic acid
Ophthalmic Solutions
Pharmaceutical Solutions
Tetrahydrozoline
Timolol